Amanote Research
Register
Sign In
464 Lupus Low Disease Activity State: Prevalence and Effect on Damage Accrual in a Monocentric Cohort of 293 Sle Patients
doi 10.1136/lupus-2017-000215.464
Full Text
Open PDF
Abstract
Available in
full text
Date
March 1, 2017
Authors
A Doria
M Zen
F Saccon
M Gatto
M Larosa
L Iaccarino
Publisher
Lupus Foundation of America
Related search
FRI0350 Lupus Low Disease Activity State (LLDAS-50) Is a Significant Predictor for Damage Accrual and Mortality: A Norwegian Cohort Analysis
FRI0352 Damage Accrual in a Large Monocentric Cohort of Primary sjÖgren’s Syndrome Patients: Determinants and Impact on Patient Reported Outcomes
Disease Activity and Damage Are Not Associated With Increased Levels of Fatigue in Systemic Lupus Erythematosus Patients From a Multiethnic Cohort: LXVII
Arthritis & Rheumatism
Association of Calreticulin Expression With Disease Activity and Organ Damage in Systemic Lupus Erythematosus Patients
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
How to Use the Lupus Low Disease Activity State (LLDAS) in Clinical Trials
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Malignancy in Systemic Lupus Erythematosus (SLE) Patients
Asian Pacific Journal of Cancer Prevention
Performance of the Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) in a Latin American Population.
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Biomarkers of Disease Activity and Organ Damage in Systemic Lupus Erythematosus
Defining Low Disease Activity in Systemic Lupus Erythematosus
Arthritis Care and Research
Rheumatology
